Search

everythinglearnresearchcommunity

for

Search:↓

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Trichogerminoma is a rare, benign skin tumor from hair cells, with a small risk of becoming cancerous.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Targeting colon cancer stem cells might lead to better treatment results.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

A 65-year-old woman has a growing bald spot on her scalp.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.